SCFAs, shortchain fatty acids
Know your eligibility
If the comparison has you reconsidering your approach, the HealthyDerm Blue Balm delivers GHK-Cu in a tallow carrier that also restores the lipid barrier, addressing two of the core issues in post-menopausal skin with a single product
Their concerns were categorized as follows: Overprescribing (clinically inappropriate prescribing): 56% Compromised continuity of care (e.g., follow-up visits, titration, tapering off medication): 50% Lack of complete medical history: 47% Medication interactions and/or side effect management: 43% Lack of transparency to the patients broader care team: 32% Prevalence of compounded GLP-1s/GIPs: 32% Lack of holistic support of weight management: 24% Researchers have raised marketing and safety concerns about compounded and counterfeit GLP-1s, and the FDA recommends that patients "obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy." However, patient demand for these drugs is likely to persist due to their significantly lower costs
Rybelsus 7mg Tablet contains Semaglutide, a medication used primarily to manage type 2 diabetes mellitus
GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances
